Archer Daniels Midland (ADM)
(Delayed Data from NYSE)
$60.62 USD
-0.37 (-0.61%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $60.63 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$60.62 USD
-0.37 (-0.61%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $60.63 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
Zacks News
Incorporated in Delaware in 1923, Archer Daniels Midland Company is successor to the Daniels Linseed Co. Founded in 1902, this Illinois-based company is one of the leading producers of food and beverage ingredients as well as goods made from various agricultural products. The company processes oilseeds, corn, wheat, cocoa and other feedstuffs. Moreover, it engages in the manufacturing, sale, and distribution of products like natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, natural health and nutrition products as well as other specialty food and feed ingredients.
ADM or LMNR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADM vs. LMNR: Which Stock Is the Better Value Option?
3 Reasons Why ADM (ADM) Is a Great Growth Stock
by Zacks Equity Research
ADM (ADM) possesses solid growth attributes, which could help it handily outperform the market.
Archer Daniels' (ADM) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Archer Daniels' (ADM) Q2 results gain from solid revenues across all segments owing to healthy demand for its products. It expects strong momentum to continue in 2021.
Archer Daniels Midland (ADM) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ADM (ADM) delivered earnings and revenue surprises of 31.68% and 26.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Archer Daniels (ADM) Ahead of Earnings?
by Zacks Equity Research
Archer Daniels (ADM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Things You Must Note Ahead of FEMSA's (FMX) Q2 Earnings
by Zacks Equity Research
FEMSA (FMX) Q2 results are expected to have witnessed from recovering economic trends, strong digital demand and momentum in FEMSA Comercio's Health division.
ADM (ADM) Loses 6.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
ADM (ADM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Is Archer Daniels Midland (ADM) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (ADM) Outperforming Other Consumer Staples Stocks This Year?
Archer Daniels Midland (ADM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
ADM (ADM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Archer Daniels (ADM) is Poised for Q2 Earnings Beat
by Zacks Equity Research
Archer Daniels' (ADM) Q2 results are expected to reflect gains from strength in the Nutrition, and Ag Services and Oilseeds units as well as persistent demand.
Will ADM (ADM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
ADM (ADM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Factors to Decide the Fate of Boston Beer (SAM) in Q2 Earnings
by Zacks Equity Research
Boston Beer (SAM) is expected to have seen continued momentum in shipments and depletions on brand strength in Q2. Sluggish brewery productivity, keg returns and high costs are likely to have hurt.
The J. M. Smucker (SJM) Cheers Investors With Dividend Hike
by Zacks Equity Research
The J.M. Smucker (SJM) is likely to cement its position in investors' good books with the latest dividend hike of 10%. Cost-saving efforts and improved Away From Home division bode well.
Monster Beverage (MNST) Rises 25.4% in a Year: More Room to Run?
by Zacks Equity Research
Monster Beverage (MNST) looks poised for growth, backed by strength in its energy drinks business as well as a robust pipeline of innovative product launches.
Here's Why You Should Hold on to AB InBev (BUD) Stock Now
by Zacks Equity Research
AB InBev (BUD) has been an investor favorite on a strong brand portfolio, commercial strategy, and investments in digital and operational excellence. Premiumization efforts have also been aiding.
Here's Why PepsiCo (PEP) Looks Poised for Earnings Beat in Q2
by Zacks Equity Research
Persistent demand for home breakfast and lite snacking trends along with robust trends in the beverage business is expected to have aided PepsiCo's (PEP) Q2 performance.
Colgate (CL) Up More Than 13% in a Year on Strategic Growth Plans
by Zacks Equity Research
Colgate's (CL) solid demand, strength in e-commerce, and robust innovation and expansion plans are likely to drive growth further.
Here's How Investors Can Find Strong Consumer Staples Stocks with the Zacks ESP Screener
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is ADM (ADM) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
ADM (ADM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Constellation Brands (STZ) Misses on Q1 Earnings, Updates View
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results gain from robust growth in the beer business despite soft wine and spirits performance. It provides an upbeat view for fiscal 2022.
ADM (ADM) Loses 10.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
ADM (ADM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Archer-Daniels-Midland (ADM) is Oversold: Can It Recover?
by Zacks Equity Research
Archer-Daniels-Midland Company (ADM) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Archer Daniels (ADM) Gains on Strategic Moves & Nutrition Unit
by Zacks Equity Research
Archer Daniels (ADM) smoothly advances on its growth pillars that assure to optimize the core, drive efficiencies and expand strategically.
3 Reasons Why You Must Hold Diageo (DEO) in Your Portfolio
by Zacks Equity Research
Diageo (DEO) is poised to retain its market position through investments in online and the booming RTD category. Higher costs and disruptions in Travel Retail and on-trade businesses are headwinds.
Colgate (CL) Invests in Pet Business to Cater to Growing Demand
by Zacks Equity Research
Colgate's (CL) Hill's Pet Nutrition unit intends to invest $250 million in building a new facility at Leavenworth County, KS, to meet growing customer demand.